Differences in Therapeutic Indexes of Combination Metronomic Chemotherapy and an Anti-VEGFR-2 Antibody in Multidrug-resistant Human Breast Cancer Xenografts
作者： Giannoula Klement , Daniel Hicklin , Shan Man , Ping Huang , Robert S. Kerbel
DOI:
关键词:
摘要: … The rationale for this combination is that anti-VEGFR-2- or … or in combination with a second drug such as anti-VEGFR-2 … drugs are used in combination with the antiangiogenic, VEGFR-2-…
aacrjournals.org
researchgate.net 参考文章(36)
W. Liu, S. A. Ahmad, N. Reinmuth, R. M. Shaheen, Y. D. Jung, F. Fan, L. M. Ellis, Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis. ,vol. 5, pp. 323- 328 ,(2000) , 10.1023/A:1009679307513
Philipp le Coutre, Elena Tassi, Marileila Varella-Garcia, Rossella Barni, Luca Mologni, Gonçalo Cabrita, Edoardo Marchesi, Rosanna Supino, Carlo Gambacorti-Passerini, Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood. ,vol. 95, pp. 1758- 1766 ,(2000) , 10.1182/BLOOD.V95.5.1758.005A41_1758_1766
Judah Folkman, Philip Hahnfeldt, Lynn Hlatky, Cancer: looking outside the genome Nature Reviews Molecular Cell Biology. ,vol. 1, pp. 76- 79 ,(2000) , 10.1038/35036100
Ie-Ming Shih, Christopher Torrance, Lori J. Sokoll, Daniel W. Chan, Kenneth W. Kinzler, Bert Vogelstein, Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin. Nature Medicine. ,vol. 6, pp. 711- 714 ,(2000) , 10.1038/76299
François Xavier Mahon, Michael W. N. Deininger, Beate Schultheis, Jérome Chabrol, Josy Reiffers, John M. Goldman, Junia V. Melo, Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance Blood. ,vol. 96, pp. 1070- 1079 ,(2000) , 10.1182/BLOOD.V96.3.1070
Philippe Gros, Marie Azzaria, Jeffrey F. Lemontt, Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells. Cancer Research. ,vol. 48, pp. 6348- 6353 ,(1988)
Thomas Boehm, Judah Folkman, Timothy Browder, Michael S. O'Reilly, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature. ,vol. 390, pp. 404- 407 ,(1997) , 10.1038/37126
Larry Witte, Daniel J. Hicklin, Zhenping Zhu, Bronislaw Pytowski, Helen Kotanides, Patricia Rockwell, Peter Böhlen, Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy. Cancer and Metastasis Reviews. ,vol. 17, pp. 155- 161 ,(1998) , 10.1023/A:1006094117427
Akinao Haba, Fumihiko Matsuno, Norihiko Takahashi, Ben K. Seon, Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide. Cancer Research. ,vol. 61, pp. 7846- 7854 ,(2001)
J D Hainsworth, H A Burris, J B Erland, M Thomas, F A Greco, Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer. Journal of Clinical Oncology. ,vol. 16, pp. 2164- 2168 ,(1998) , 10.1200/JCO.1998.16.6.2164